(R)-2-(Methoxymethyl)morpholine hydrochloride

Catalog No.: 
ACJOOM880
CAS No.: 
141196-39-6
Molecular Formula: 
C6H14ClNO2
Molecular Weight: 
167.64
(R)-2-(Methoxymethyl)morpholine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$62.00In stockIn stock
5g98%$199.00In stockIn stock
25g98%$756.00In stockInquiry
100g98%$2519.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-2-(Methoxymethyl)morpholine hydrochloride
IUPAC Name(R)-2-(Methoxymethyl)morpholine hydrochloride
MDL No.MFCD16294689
Molecular FormulaC6H14ClNO2
Molecular Weight167.64
SMILESCOC[C@H]1CNCCO1.[H]Cl
InChI KeyNBPHWKGEMABLPV-FYZOBXCZSA-N
Synonym(R)-2-(Methoxymethyl)morpholine hydrochloride | 141196-39-6 | (R)-2-(Methoxymethyl)morpholine HCl | (2R)-2-(methoxymethyl)morpholine;hydrochloride | (R)-2-Methoxymethyl-morpholine hydrochloride | SCHEMBL3942366 | DTXSID90693465 | MFCD16294689 | AKOS016007880 | CS-W018994 | D
CAS No.141196-39-6
PubChem CID53338716

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJOOM880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJOOM880 route product structure diagram
    ACJOOM880141196-39-6In Stock
Inquiry

2. ACJOOM880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJOOM880 route product structure diagram
    ACJOOM880141196-39-6In Stock
Inquiry

3. ACJOOM880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJOOM880 route product structure diagram
    ACJOOM880141196-39-6In Stock
Inquiry

Comments (0)